
Please try another search
BLIS Technologies Limited, together with its subsidiaries, develops and sells healthcare products based on strains of bacteria that produce bacteriocin activity. The company offers BLIS K12, an oral probiotic supplement to support ear, nose, and throat health, as well as for enhancing immunity and bad breath; BLIS M18, an oral probiotic to support teeth and gums health; and BLIS Q24, a probiotic supplement to balance the skin microbiome, restoring the health, clarity, and radiance. It also provides its products in the ENT, immune, dental, and skin areas. The company has operations in New Zealand, Asia Pacific, Europe Middle East and Africa, and North America. The company was incorporated in 2000 and is based in Dunedin, New Zealand.
Name | Age | Since | Title |
---|---|---|---|
Barry C. Richardson | - | 2006 | Independent Non-Executive Director |
Alison Stewart | 67 | 2018 | Independent Non-Executive Director |
Geoffrey Plunket | - | 2018 | Independent Chairman |
Amelia McCammon | - | 2021 | Independent Non-Executive Director |
Anita Johansen | 53 | 2024 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review